Sector ratings Bristol-Myers Squibb Company

Equities

Real-time Estimate Cboe BZX Other stock markets 10:31:56 2026-03-09 am EDT			5-day change	1st Jan Change
59.35 ^USD	-1.56%		-4.14%	+10.79%

08:09am	Bristol Myers Squibb Says Blood-Cancer Treatment Performed Well in Late-Stage Trial	DJ
07:21am	Bristol's drug enhances survival rates in late-stage blood cancer trial	RE

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI
BRISTOL-MYERS SQUIBB COMPANY	123B	A
ELI LILLY AND COMPANY	885B	A
JOHNSON & JOHNSON	579B	BBB
ABBVIE INC.	407B	AA
ROCHE HOLDING AG	350B	AA
NOVARTIS AG	302B	AAA
ASTRAZENECA PLC	301B	A
MERCK & CO., INC.	286B	A
AMGEN INC.	199B	A
GILEAD SCIENCES, INC.	179B	AAA
NOVO NORDISK A/S	171B	A
PFIZER INC.	154B	BBB
VERTEX PHARMACEUTICALS INCORPORATED	116B	AA
GSK PLC	109B	AA
SANOFI	107B	A
CHUGAI PHARMACEUTICAL CO., LTD.	100B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	57B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.42B	AA
HALEON PLC	44.97B	AA
ALNYLAM PHARMACEUTICALS, INC.	42.53B	AA
Average	228.33B	AA
Weighted average by Cap.		AA